Experimental Alzheimer’s Drug Shows Promise in Trial
The research shows that Lecanemab reduced symptoms by 27%.
Most Popular
Articles
- Man faces multiple charges after early morning traffic stop in Reno
- Man arrested after hours-long standoff in Virginia City Highlands
- Fernley Intermediate School substitute loses job after allegedly grabbing two students by neck
- Mountain lion seen near Downieville courthouse prompts alert
- Suspect arrested in series of armed robberies, including Tamarack Casino, Walmart, Atlantis
- Gas prices reach highest point since start of war with Iran
- Months-long investigation leads to arrest tied to alleged firearm possession, registration violations
- Driver identified after deadly crash on SR 290 north of Winnemucca
- Crash aftermath reveals confrontation before deadly hit-and-run in Sparks
- Justice Department moves to roll back gun regulations as Senate confirms new ATF chief
Powered by BLOX Content Management System from BLOX Digital.
You don't have any notifications.
Get up-to-the-minute news sent straight to your device.
